High Throughput Screening Market Research Report Market Forecast till 2030
상품코드:1473723
리서치사:Market Research Future
발행일:2024년 04월
페이지 정보:영문 167 Pages
라이선스 & 가격 (부가세 별도)
한글목차
High Throughput Screening 시장 규모는 예측 기간 중 9.70%의 CAGR로 성장할 것으로 예측되고 있습니다.
시장 성장의 요인으로서는 게놈 연구의 발전, 맞춤형 의료에 대한 관심의 증가, 연구개발 투자의 증가, 인지도의 향상과 채택의 증가를 들 수 있습니다.
High Throughput Screening 시장은 맞춤형 의료에 대한 관심의 증가에 의해 대폭적인 성장을 달성하고 있습니다. 대량의 DNA 및 RNA 염기 배열을 신속하고 비용 효율적으로 결정할 수 있는 High Throughput Screening은 맞춤형 의료의 진보에서 매우 중요한 역할을 담당하고 있습니다.
지역별 인사이트
2022년의 시장 점유율에서는 북미 지역이 42.96%로 최대 규모를 보이며, 예측 기간 중 CAGR에서는 아시아태평양이 11.01%로 최대 성장을 보일 전망입니다. 이 시장의 성장은 세계에서의 임상시험 수의 증가 및 R&D의 확대에 의해 추진되고 있습니다.
유럽의 High Throughput Screening 시장의 성장은 신약 리드 분자의 발견을 가속하기 위한 HTS 프로젝트의 추진에 의해 초래되고 있습니다.
세계의 High Throughput Screening 시장을 조사했으며, 시장의 정의와 개요, 시장 성장에 대한 영향요인 및 시장 기회의 분석, 시장 규모의 추이·예측, 각종 구분·지역별 내역, 경쟁 환경, 주요 기업의 개요 등을 정리하여 전해드립니다.
목차
제1장 주요 요약
제2장 시장 개요
제3장 조사 방법
제4장 시장 역학
개요
촉진요인
게놈 연구 활동의 확대
맞춤형 의료의 수요가 높아진다.
R&D 투자의 증가
억제요인
초기의 고비용
기회
인지도와 채택의 향상
제5장 시장 요인 분석
밸류체인 분석
Porter's Five Forces 분석
COVID-19가 세계의 High Throughput Screening 시장에 미치는 영향
제6장 세계의 High Throughput Screening 시장 : 제품·서비스별
개요
소모품
기기
소프트웨어·서비스
제7장 세계의 High Throughput Screening 시장 : 기술별
개요
세포 기반 어세이
3차원 배양
랩온어칩(LOC)
ULTRA-High Throughput Screening
라벨 프리 기술
기타
제8장 세계의 High Throughput Screening 시장 : 용도별
개요
Drug Discovery
생화학 스크리닝
세포 및 장기 기반 스크리닝
기타
제9장 세계의 High Throughput Screening 시장 : 최종사용자별
개요
제약·바이오테크놀러지 기업
연구기관 및 조직
CRO
제10장 세계의 High Throughput Screening 시장 : 지역별
개요
북미
유럽
아시아태평양
기타 지역
제11장 경쟁 구도
개요
경쟁 벤치마킹
주요 성장 전략
개발 건수면에서의 TOP 기업
주요 개발 분석
주요 개발·성장 전략
재무 매트릭스
제12장 기업 개요
CORNING INCORPORATED
AGILENT TECHNOLOGIES, INC
LUMINEX CORPORATION
F. HOFFMANN-LA ROCHE LTD
PROMEGA CORPORATION
MERCK KGAA
TECAN TRADING AG
PERKINELMER INC
BECKMAN COULTER, INC
HAMILTON COMPANY
제13장 부록
KSA
영문 목차
영문목차
Market Overview
High Throughput Screening Market is anticipated to register a significant CAGR of 9.70% during the forecast period.
The variables adding to the development of the market are the developing genomic research exercises, rising interest for customized medication, expanding interest in innovative work, and expanding mindfulness and reception.
The high-throughput screening market is encountering significant development because of the rising interest for customized medication. Customized medication, otherwise called accuracy medication, is an inventive methodology that thinks about a singular's exceptional hereditary cosmetics, way of life, and natural variables to tailor clinical medicines and mediations. High-throughput screening, with its capacity to succession enormous volumes of DNA or RNA quickly and cost-really, assumes a crucial part in the headway of customized medication. One of the essential drivers behind the rising interest for customized medication is the developing acknowledgment that people answer diversely to medicines because of their one-of-a-kind hereditary variety. High-throughput screening empowers the ID of sickness related hereditary variations and offers bits of knowledge into the hereditary variables fundamental the viability and security of explicit treatments. By breaking down a person's hereditary data, medical care experts can decide the most appropriate therapy choices and upgrade measurements, bringing about superior patient results.
Market Segment Insights
Based on product & service, the High Throughput Screening Market has been segmented into consumables, instruments, and software & services. Based on technology, the Market has classified into cell-based assays, Lab-on-a-Chip (LOC), ultra-high-throughput screening, label-free technology, and others.
Based on application, the High Throughput Screening Market has segmented into drug discovery, biochemical screening, cell & organ-based screening, and others. In terms of end user, the Market has categorized into pharmaceutical and biotechnology companies, research institutes and organizations, and contract research organizations.
Regional Insights
North America represented the biggest market portion of 42.96% in 2022 and Asia-Pacific is projected to develop at the highest CAGR of 11.01% during the figure time frame. Moreover, market development is driven by expanding clinical preliminary numbers across the globe, and developing exploration and improvement. In addition, the underneath diagram addresses the quantity of clinical preliminaries for every region began in 2022. The market development has been driven by inorganic procedures to extend high-throughput screening (HTS) answers for measure biochemical exercises and recognize restricting associations, which speed up the timetable and lessen expenses to distinguish lead drug competitors. For example, in January 2023, Charles Waterway Research Facilities Global, Inc. (US) procured SAMDI Tech, Inc. (US), a main supplier of HTS answers for grow HTS portfolio.
The development of the European high-throughput screening market is driven by elevating HTS undertakings to speed up the revelation of a lead particle for another medication. For example, in Walk 2023, SCREENTECH opened under the correlative arrangement for biotechnology in Catalonia (Spain). This drive focused on the advancement of new ventures in view of the medication screening and medication target connection examination stage at IRB Barcelona (US).
In addition, the high guilty pleasure of high-throughput screening fire up designers like CN Bio (UK), Evosep (Denmark), Ovizio (Belgium), and Oxford Nanopore Advancements plc. (UK) through raising financing and consolidating advancement is setting out enormous open doors for the region's development.
Major Players
Key Companies in the High Throughput Screening Market are Agilent Technologies Inc, Merck KGaA, Corning Incorporated, Tecan Trading AG, PerkinElmer Inc, Luminex Corporation, Beckman Coulter Inc, Hoffmann-La Roche Ltd, Promega Corporation, Hamilton Company, and Others.
TABLE OF CONTENTS
1 EXECUTIVE SUMMARY
1.1 OVERVIEW
2 MARKET INTRODUCTION
2.1 DEFINITION
2.2 SCOPE OF THE STUDY
2.3 RESEARCH OBJECTIVE
2.4 MARKET STRUCTURE
2.5 ASSUMPTIONS & LIMITATIONS
3 RESEARCH METHODOLOGY
3.1 DATA MINING
3.2 SECONDARY RESEARCH
3.3 PRIMARY RESEARCH
3.4 BREAKDOWN OF PRIMARY RESPONDENTS
3.5 FORECASTING TECHNIQUES
3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION
3.6.1 BOTTOM-UP APPROACH
3.6.2 TOP-DOWN APPROACH
3.7 DATA TRIANGULATION
3.8 VALIDATION
4 MARKET DYNAMICS
4.1 OVERVIEW
4.2 DRIVERS
4.2.1 GROWING GENOMIC RESEARCH ACTIVITIES
4.2.2 RISING DEMAND FOR PERSONALIZED MEDICINE
4.2.3 INCREASING INVESTMENT IN RESEARCH AND DEVELOPMENT
4.3 RESTRAINTS
4.3.1 HIGH INITIAL SETUP COSTS
4.4 OPPORTUNITY
4.4.1 INCREASING AWARENESS AND ADOPTION
5 MARKET FACTOR ANALYSIS
5.1 VALUE CHAIN ANALYSIS
5.1.1 R&D & DESIGNING
5.1.2 MANUFACTURING
5.1.3 DISTRIBUTION & SALES
5.1.4 POST-SALES MONITORING
5.2 PORTER'S FIVE FORCES MODEL
5.2.1 THREAT OF NEW ENTRANTS
5.2.2 BARGAINING POWER OF SUPPLIERS
5.2.3 THREAT OF SUBSTITUTES
5.2.4 BARGAINING POWER OF BUYERS
5.2.5 INTENSITY OF RIVALRY
5.3 IMPACT OF COVID-19 ON THE GLOBAL HIGH THROUGHPUT SCREENING MARKET
5.3.1 IMPACT ON SUPPLY CHAIN
5.3.2 IMPACT ON PRODUCTION
5.3.3 IMPACT ON REGION
5.3.4 IMPACT ON PRICING
6 GLOBAL HIGH THROUGHPUT SCREENING MARKET, BY PRODUCTS & SERVICES
6.1 OVERVIEW
6.2 CONSUMABLES
6.3 INSTRUMENTS
6.4 SOFTWARE & SERVICES
7 GLOBAL HIGH THROUGHPUT SCREENING MARKET, BY TECHNOLOGY
7.1 OVERVIEW
7.2 CELL-BASED ASSAYS
7.2.1D CELL CULTURE
7.3 LAB-ON-A-CHIP (LOC)
7.4 ULTRA-HIGH-THROUGHPUT SCREENING
7.5 LABEL-FREE TECHNOLOGY
7.6 OTHERS
8 GLOBAL HIGH THROUGHPUT SCREENING MARKET, BY APPLICATION
8.1 OVERVIEW
8.2 DRUG DISCOVERY
8.3 BIOCHEMICAL SCREENING
8.4 CELL- & ORGAN-BASED SCREENING
8.5 OTHERS
9 GLOBAL HIGH THROUGHPUT SCREENING MARKET, BY END USER
9.1 OVERVIEW
9.2 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
9.3 RESEARCH INSTITUTES AND ORGANISATIONS
9.4 CONTRACT RESEARCH ORGANIZATIONS
10 GLOBAL HIGH THROUGHPUT SCREENING MARKET, BY REGION
10.1 OVERVIEW
10.2 NORTH AMERICA
10.2.1 US
10.2.2 CANADA
10.3 EUROPE
10.3.1 GERMANY
10.3.2 FRANCE
10.3.3 UK
10.3.4 ITALY
10.3.5 SPAIN
10.3.6 REST OF EUROPE
10.4 ASIA-PACIFIC
10.4.1 CHINA
10.4.2 JAPAN
10.4.3 INDIA
10.4.4 SOUTH KOREA
10.4.5 AUSTRALIA
10.4.6 REST OF ASIA-PACIFIC
10.5 REST OF THE WORLD
10.5.1 MIDDLE EAST
10.5.2 AFRICA
10.5.3 LATIN AMERICA
11 COMPETITIVE LANDSCAPE
11.1 OVERVIEW
11.2 COMPETITIVE BENCHMARKING
11.3 MAJOR GROWTH STRATEGY IN THE GLOBAL HIGH THROUGHPUT SCREENING MARKET
11.4 THE LEADING PLAYER IN TERMS OF THE NUMBER OF DEVELOPMENTS IN THE GLOBAL HIGH THROUGHPUT SCREENING MARKET
11.5 KEY DEVELOPMENT ANALYSIS
11.6 KEY DEVELOPMENTS & GROWTH STRATEGIES
11.6.1 PRODUCT/COMPANY LAUNCH/PRODUCT APPROVAL
11.6.2 COLLABORATION/AGREEMENT
11.6.3 ACQUISITION/MERGER
11.7 FINANCIAL MATRIX
11.7.1 SALES (USD MILLION),
11.7.2 RESEARCH & DEVELOPMENT EXPENDITURE (USD MILLION),
